Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Huazhi Rougan granules in nonalcoholic simple fatty liver (damp-heat obstruction pattern)
CTR20192578Phase 4Completed
- Sponsor
- Shandong New Era Pharmaceutical
- Start
- Dec 2019
- Countries
- 1
01
Overview
A Phase 4 trial of huazhi rougan granule in metabolic dysfunction-associated steatotic liver disease (MASLD), sponsored by Shandong New Era Pharmaceutical. Started Dec 2019; status: completed.
02
Drugs
huazhi rougan granule
03
Conditions
metabolic dysfunction-associated steatotic liver disease (MASLD)
Beyond the preview
Go deeper on CTR20192578.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20192578.